No abstract

Graphene nanosheets are highly recognized for their utility toward the development of biomedical device applications. The present study investigated the antibacterial efficiency of graphene nanosheets against four types of pathogenic bacteria. Graphene nanosheets are synthesized by a hydrothermal approach (under alkaline conditions using hydrazine hydrate). UV–vis and X-ray diffraction show a maximum absorbance at 267 nm and appearance of new broad diffraction peak at 26°, which ensures the reduction of graphene oxide into graphene nanosheets. Stretching and bending vibrations of C–C bonds, chemical states, disorder, and defects associated with the graphene nanosheets are evaluated in comparison with graphene oxide. The minimum inhibitory concentration (MIC) of graphene nanosheets against pathogenic bacteria was evaluated by a microdilution method. MICs such as 1 μg/mL (against Escherichia coli and Salmonella typhimurium), 8 μg/mL (against Enterococcus faecalis), and 4 μg/mL (against Bacillus subtilis) suggest that graphene nanosheets have predominant antibacterial activity compared to the standard antibiotic, kanamycin. Measurement of free radical modulation activity of graphene nanosheets suggested the involvement of reactive oxygen species in antibacterial properties.

No abstract

Rapid innovations in nanomedicine have increased the likelihood that engineered nanomaterials will eventually come in contact with humans and the environment. The advent of nanotechnology has created strong interest in many fields such as biomedical sciences and engineering field. Central to any significant advances in nanomaterial based applications will be the development of functionalized nanoparticles, which are believed to hold promise for use in fields such as pharmaceutical and biomedical sciences. Early clinical results have suggested that functionalization of nanoparticles with specific recognition chemical moieties indeed yields multifunctional nanoparticles with enhanced efficacy, while simultaneously reducing side effects, due to properties such as targeted localization in tumors and active cellular uptake. A prerequisite for advancing this area of research is the development of chemical methods to conjugate chemical moieties onto nanoparticles in a reliable manner. In recent years a variety of chemical methods have been developed to synthesize functionalized nanoparticles specifically for drug delivery, cancer therapy, diagnostics, tissue engineering and molecular biology, and the structure-function relationship of these functionalized nanoparticles has been extensively examined. With the growing understanding of methods to functionalize nanoparticles and the continued efforts of creative scientists to advance this technology, it is likely that functionalized nanoparticles will become an important tool in the above mentioned areas. Therefore, the aim of this review is to provide basic information on nanoparticles, describe previously developed methods to functionalize nanoparticles and discuss their potential applications in biomedical sciences. The information provided in this review is important in regards to the safe and widespread use of functionalized nanoparticles particularly in the biomedicine field.

No abstract

No abstract

Biological efficiency of existing antimicrobial agents is still inadequate to ensure optimal therapeutic index. Developing biocompatible advanced functional materials with antimicrobial properties could be promising for environmentally benign applications. Nanoparticles and other nanoscale materials are of great interest due to their multiple potential applications in material science, medicine, and industry. Nanomaterials possess well renowned antimicrobial activity against several microorganisms; however, it has some non-specific toxicity. Biofunctionalization of nanomaterials is one such topic to address this issue. Rational selection of therapeutically active biomolecules for design of nanoparticles will certainly increase the biological applicability. The present paper describes the current status of different types of biofunctionalized nanoparticles and their antibacterial applications. Key principles such as strategies involved at bio-/nanointerface, the structural activity relationship, and mechanism of action involved in the antibacterial activity of functionalized nanoparticles are briefly discussed. This knowledge is important from the objective of generation of advanced functional nanomaterials with antimicrobial properties.

No abstract